Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Angiogenic growth factor secretion" refers to the process by which various cell types—including endothelial cells, fibroblasts, and tumor cells—release signaling proteins known as angiogenic growth factors into their environment. These secreted factors, such as vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), and platelet-derived growth factor (PDGF), act in paracrine and autocrine fashions to stimulate the sprouting, proliferation, and migration of endothelial cells, ultimately forming new blood vessels. This process is tightly regulated and is critical for physiological events such as embryonic development, tissue repair, and regeneration, but also plays a key role in pathological states like cancer, where aberrant or excessive secretion of angiogenic growth factors drives tumor vascularization and progression[1][3][4][5][6][7][12].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Angiogenic growth factor secretion.